Diabetes, Vol 40, Issue 5 540-547, Copyright © 1991 by American Diabetes Association

ARTICLES

Effects of nonenzymatic glycosylation of mesangial matrix on proliferation of mesangial cells

ST Crowley, M Brownlee, D Edelstein, JA Satriano, T Mori, PC Singhal and DO Schlondorff
Department of Medicine, Albert Einstein College of Medicine, Bronx, NY 10461.

Cross-linking of cell matrix components by nonenzymatic glycosylation may contribute to diabetic glomerulopathy. We examined the effects of modification of matrix by nonenzymatic glycosylation on mesangial cell function. Matrix was generated by growing mesangial cells in tissue culture for 2 wk and removing the cells with a detergent cell-lysis solution. By indirect immunofluorescence and Northern-blot analysis, the remaining matrix contained laminin, fibronectin, and collagens type I and IV. The matrix was modified by incubation for 24 h with 50 mM glycolaldehyde, a highly reactive cross-linking nonenzymatic glycosylation product, or for 2 wk with 200 mM glucose-6-phosphate (G6P). Modification was carried out with or without equimolar aminoguanidine, an inhibitor of cross-link formation. Nonenzymatic glycosylation of the matrix by glycolaldehyde or G6P was confirmed by fluorometry and [14C]G6P incorporation and was prevented by aminoguanidine. [3H]thymidine incorporation for 24 h by mesangial cells plated onto unmodified or modified matrix was then performed. Modification of matrix had no effect on attachment of mesangial cells, determined 4 h after plating. Nonenzymatic glycosylation of matrix by glycolaldehyde or G6P significantly inhibited thymidine incorporation by mesangial cells. This effect was partially reversible by aminoguanidine. Aminoguanidine-modified matrix had no effect on thymidine incorporation. Thymidine-incorporation results were confirmed by direct cell counting. We conclude that modification of matrix by nonenzymatic glycosylation influences growth of mesangial cells, which could contribute to the mesangial abnormalities of diabetic glomerulopathy.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				R H M King The role of glycation in the pathogenesis of diabetic polyneuropathy Mol. Pathol., December 1, 2001; 54(6): 400 - 408. [Abstract] [Full Text] [PDF]

				G. Xiang, R. Schinzel, A. Simm, G. Munch, K. Sebekova, M. Kasper, T. Niwa, C. Schmitz, and A. Heidland Advanced glycation end products (AGEs)-induced expression of TGF-{beta}1 is suppressed by a protease in the tubule cell line LLC-PK1 Nephrol. Dial. Transplant., August 1, 2001; 16(8): 1562 - 1569. [Abstract] [Full Text] [PDF]

				P. MENÈ, C. PASCALE, A. TETI, S. BERNARDINI, G. A. CINOTTI, and F. PUGLIESE Effects of Advanced Glycation End Products on Cytosolic Ca2+ Signaling of Cultured Human Mesangial Cells J. Am. Soc. Nephrol., July 1, 1999; 10(7): 1478 - 1486. [Abstract] [Full Text]